The role of alterations in BRCA1, BRCA2, TP53 and ATM genes in sporadic breast tumors

被引：0
|
作者：
Ticha, I. [1 ]
Soukupova, J. [1 ]
Janatova, M. [1 ]
Kleibl, Z. [1 ]
Pohlreich, P. [1 ]
机构：
[1] Charles Univ Prague, Fac Med 1, Inst Biochem & Expt Oncol, Prague, Czech Republic
来源：
EJC SUPPLEMENTS | 2008年 / 6卷 / 09期
关键词：
D O I：
10.1016/S1359-6349(08)71623-9
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：118 / 118
页数：1
相关论文
共 50 条
  • [31] Analytical and technical validation of a cost-effective diagnostic test for BRCA1, BRCA2 and TP53
    Sen, Manimala
    Agrawal, Pooja
    Vittal, Vikram P.
    Ghosh, Mithua
    Sheela, M. L.
    Vishwanath, Divya
    Kumari, Kiran
    Swetha, N. S. N.
    Pathak, Vaibhavi
    Deshpande, Gouri
    Mannan, Ashraf
    Gadkari, Rupali
    Kapoor, Suman
    Yadhav, Jamuna
    Yousuff, Mohammed
    Sankaran, Satish
    Hariharan, Ramesh
    Ramamoorthy, Preveen
    Subramanian, Kalyanasundaram
    Gupta, Vaijayanti
    CANCER RESEARCH, 2015, 75
  • [32] Frequency of Pathogenic Germline Variants in CDH1, BRCA2, CHEK2, PALB2, BRCA1, and TP53 in Sporadic Lobular Breast Cancer
    Petridis, Christos
    Arora, Iteeka
    Shah, Vandna
    Moss, Charlotte L.
    Mera, Anca
    Clifford, Angela
    Gillett, Cheryl
    Pinder, Sarah E.
    Tomlinson, Ian
    Roylance, Rebecca
    Simpson, Michael A.
    Sawyer, Elinor J.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2019, 28 (07) : 1162 - 1168
  • [33] BRCA1 and BRCA2 genes:: Role in hereditary breast and ovarian cancer in Italy
    Santarosa, M
    Dolcetti, R
    Magri, MD
    Crivellari, D
    Tibiletti, MG
    Gallo, A
    Tumolo, S
    Della Puppa, L
    Furlan, D
    Boiocchi, M
    Viel, A
    INTERNATIONAL JOURNAL OF CANCER, 1999, 83 (01) : 5 - 9
  • [34] BRCA1 and BRCA2 mutation screening in sporadic and familial breast cancer
    Ellis, D
    McCall, SH
    Greenman, J
    Evans, G
    Abbs, S
    Hodgson, SV
    Mathew, CG
    JOURNAL OF MEDICAL GENETICS, 1999, 36 : S38 - S38
  • [35] The role of BRCA1 AND BRCA2 in hereditary breast cancer
    Christopoulou, Athina
    Spiliotis, John
    GENE THERAPY AND MOLECULAR BIOLOGY, 2006, 10A : 95 - 99
  • [36] Beyond BRCA1 and BRCA2 wild-type breast and/or ovarian cancer families: germline mutations in TP53 and PTEN
    Blanco, A.
    Grana, B.
    Fachal, L.
    Santamarina, M.
    Cameselle-Teijeiro, J.
    Ruiz-Ponte, C.
    Carracedo, A.
    Vega, A.
    CLINICAL GENETICS, 2010, 77 (02) : 193 - 196
  • [37] The founder mutations in the BRCA1, BRCA2, and ATM genes in Moroccan Jewish women with breast cancer
    Kreiss, Y
    Barak, F
    Baruch, RG
    Levy-Lahad, E
    Pras, E
    Friedman, E
    GENETIC TESTING, 2000, 4 (04): : 403 - 407
  • [38] Expression and function of BRCA1 and BRCA2 in familial and sporadic breast cancer
    Barnes, DM
    HISTOPATHOLOGY, 1999, 34 (02) : 170 - 174
  • [39] Chromosome 5 imbalance mapping in breast tumors from BRCA1 and BRCA2 mutation carriers and sporadic breast tumors
    Johannsdottir, Hrefna K.
    Jonsson, Goran
    Johannesdottir, Gudrun
    Agnarsson, Bjarni A.
    Eerola, Hannaleena
    Arason, Adalgeir
    Heikkila, Paivi
    Egilsson, Valgardur
    Olsson, Hakan
    Johannsson, Oskar Th.
    Nevanlinna, Heli
    Borg, Ake
    Barkardottir, Rosa B.
    INTERNATIONAL JOURNAL OF CANCER, 2006, 119 (05) : 1052 - 1060
  • [40] Genetic predisposition for breast cancer: BRCA1 and BRCA2 genes
    Narod, Steven A.
    Rodriguez, Adriana A.
    SALUD PUBLICA DE MEXICO, 2011, 53 (05): : 420 - 429
12345